NO20070129L - Ny anvendelse av peptidforbindelser for behandling av amyotropisk lateral sklerose - Google Patents

Ny anvendelse av peptidforbindelser for behandling av amyotropisk lateral sklerose

Info

Publication number
NO20070129L
NO20070129L NO20070129A NO20070129A NO20070129L NO 20070129 L NO20070129 L NO 20070129L NO 20070129 A NO20070129 A NO 20070129A NO 20070129 A NO20070129 A NO 20070129A NO 20070129 L NO20070129 L NO 20070129L
Authority
NO
Norway
Prior art keywords
treatment
lateral sclerosis
amyotrophic lateral
peptide compounds
new use
Prior art date
Application number
NO20070129A
Other languages
English (en)
Inventor
Thomas Stohr
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04013636A external-priority patent/EP1604656A1/en
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of NO20070129L publication Critical patent/NO20070129L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sammendrag Den foreliggende oppfinnelse er rettet mot anvendelse av en klasse av peptidforbindelser for behandling av amyotrofisk lateralsklerose (ALS) og andre former for motornevronsykdommer og perifere nevropatier.
NO20070129A 2004-06-09 2007-01-08 Ny anvendelse av peptidforbindelser for behandling av amyotropisk lateral sklerose NO20070129L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57806304P 2004-06-09 2004-06-09
EP04013636A EP1604656A1 (en) 2004-06-09 2004-06-09 Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
PCT/EP2005/006169 WO2005120476A2 (en) 2004-06-09 2005-06-08 Novel use of peptide compounds for treating amyotrophic lateral sclerosis

Publications (1)

Publication Number Publication Date
NO20070129L true NO20070129L (no) 2007-03-06

Family

ID=35219356

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070129A NO20070129L (no) 2004-06-09 2007-01-08 Ny anvendelse av peptidforbindelser for behandling av amyotropisk lateral sklerose

Country Status (2)

Country Link
IL (1) IL179528A0 (no)
NO (1) NO20070129L (no)

Also Published As

Publication number Publication date
IL179528A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
UA87843C2 (ru) Применение пептидных соединений для лечения расстройств функционирования мотонейронов или/и периферических невропатий
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
MA30085B1 (fr) Traitement du diabete de type 2 avec une association d'un inhibiteur de dpiv et de metformine ou d'une thiazolidinedione
GB0318447D0 (en) Therapeutic agents
ATE443043T1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
DK1414494T3 (da) Hæmmende antistoffer af HER3-aktivitet
IS8058A (is) Sýklísk súlfónamíð til að hamla gamma seytiasa
GB0225475D0 (en) Therapeutic agents
ATE458753T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
ATE343388T1 (de) Pde-v hemmer zur behandlung von morbus parkinson
MA28176A1 (fr) Inhibiteurs de la forme mutante du kit
EA200801481A1 (ru) 5-(арилсульфонил)пиразолопиперидины
EA200401114A3 (ru) Замещённые гидроксиэтиламины
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
ATE489948T1 (de) Behandlung von autoimmunkrankheiten
EA200601889A1 (ru) Лечение инфекционных заболеваний
CY1110881T1 (el) Παραγωγα κιναζολινης χρησιμα στη θεραπεια περιφερικης αρτηριακης νοσου και ως αναστολεις της φωσφοδιεστερασης
ATE371724T1 (de) Behandlung neurodegenerativer krankheiten
ATE392471T1 (de) Behandlung neurodegenerativer krankheiten durch verwendung von scd4-inhibitoren
BRPI0417105A (pt) métodos de tratamento de doenças autoimunológicas em pacientes
SE0101082D0 (sv) Novel use
NO20070129L (no) Ny anvendelse av peptidforbindelser for behandling av amyotropisk lateral sklerose
EA200501259A1 (ru) Комбинированное применение фибрата и орлистата для лечения ожирения
DE60330233D1 (de) Arsentherapie zur behandlung von autoimmunerkrankungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application